David L. Suskind

4.4k total citations
72 papers, 2.2k citations indexed

About

David L. Suskind is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, David L. Suskind has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Genetics, 33 papers in Surgery and 19 papers in Epidemiology. Recurrent topics in David L. Suskind's work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (17 papers) and Gastrointestinal motility and disorders (14 papers). David L. Suskind is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Microscopic Colitis (17 papers) and Gastrointestinal motility and disorders (14 papers). David L. Suskind collaborates with scholars based in United States, Austria and Saudi Arabia. David L. Suskind's co-authors include Ghassan Wahbeh, Timothy L. Zisman, Dale Lee, Christopher J. Damman, Heather Nielson, Michele L. Shaffer, Dennis L. Christie, Matthew J. Giefer, Stephen M. Vindigni and Marcus O. Muench and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

David L. Suskind

67 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Suskind United States 28 868 782 637 627 479 72 2.2k
Dale Lee United States 24 1.3k 1.5× 977 1.2× 768 1.2× 858 1.4× 441 0.9× 63 2.7k
Raja Affendi Raja Ali Malaysia 23 618 0.7× 1.2k 1.5× 551 0.9× 606 1.0× 367 0.8× 95 2.7k
Charlotte Hedin Sweden 21 716 0.8× 848 1.1× 405 0.6× 358 0.6× 263 0.5× 58 1.8k
Eun Soo Kim South Korea 29 627 0.7× 648 0.8× 788 1.2× 729 1.2× 424 0.9× 170 3.0k
Susan J. Connor Australia 23 788 0.9× 1.2k 1.5× 550 0.9× 729 1.2× 562 1.2× 105 2.7k
Jonas Zeitz Switzerland 22 920 1.1× 720 0.9× 396 0.6× 845 1.3× 254 0.5× 60 2.2k
Masaya Sasaki Japan 27 998 1.1× 576 0.7× 771 1.2× 621 1.0× 388 0.8× 126 2.7k
Joseph H. Sellin United States 32 564 0.6× 1.2k 1.5× 873 1.4× 500 0.8× 579 1.2× 100 3.1k
Gauree G. Konijeti United States 19 1.2k 1.3× 388 0.5× 592 0.9× 902 1.4× 246 0.5× 52 2.0k
Anna Pulimood India 27 378 0.4× 378 0.5× 770 1.2× 602 1.0× 213 0.4× 70 2.1k

Countries citing papers authored by David L. Suskind

Since Specialization
Citations

This map shows the geographic impact of David L. Suskind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Suskind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Suskind more than expected).

Fields of papers citing papers by David L. Suskind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Suskind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Suskind. The network helps show where David L. Suskind may publish in the future.

Co-authorship network of co-authors of David L. Suskind

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Suskind. A scholar is included among the top collaborators of David L. Suskind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Suskind. David L. Suskind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Hengqi, David L. Suskind, Gregory J. Morton, et al.. (2024). Mo2041 CHARACTERIZING THE INTESTINAL CHONDROITIN SULFATE GLYCOSAMINOGLYCAN SULFATION SIGNATUTE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology. 166(5). S–1208. 1 indexed citations
2.
3.
Pasternak, Brad, Jonathan Moses, David L. Suskind, et al.. (2024). Characterization of Biologic Discontinuation Among Pediatric Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 22(10). 2075–2083.e1. 1 indexed citations
4.
Green, Nicole, David L. Suskind, Marshall Brown, et al.. (2024). The impact of a whole foods dietary intervention on gastrointestinal symptoms, inflammation, and fecal microbiota in pediatric patients with cystic fibrosis: A pilot study. Clinical Nutrition. 43(11). 156–163. 1 indexed citations
5.
Lee, Dale, Christopher E. Pope, Hillary S. Hayden, et al.. (2024). Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial. Journal of Pediatric Gastroenterology and Nutrition. 78(5). 1135–1142. 2 indexed citations
6.
Diener, Christian, Tomasz Wilmanski, David L. Suskind, et al.. (2024). Aberrant bowel movement frequencies coincide with increased microbe-derived blood metabolites associated with reduced organ function. Cell Reports Medicine. 5(7). 101646–101646. 6 indexed citations
7.
Yarur, Andrés, et al.. (2024). The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization. The American Journal of Gastroenterology. 120(1). 98–105. 2 indexed citations
8.
Kaplan, Jess L., Jonathan Moses, Brad Pasternak, et al.. (2023). AMINOSALICYLATE USE IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE. Inflammatory Bowel Diseases. 29(Supplement_1). S33–S33.
9.
10.
Zheng, Hengqi, M. Teresa de la Morena, & David L. Suskind. (2021). The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease. Frontiers in Immunology. 12. 675186–675186. 32 indexed citations
11.
Grevich, Sriharsha, et al.. (2019). Parental Perception of Dietary Intervention in Juvenile Idiopathic Arthritis. The Journal of Alternative and Complementary Medicine. 25(6). 643–647. 6 indexed citations
12.
Suskind, David L., et al.. (2018). Clinical Remission and Normalization of Laboratory Studies in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis Using Dietary Therapy. Journal of Pediatric Gastroenterology and Nutrition. 67(1). e15–e18. 4 indexed citations
13.
Braly, Kimberly, Michele L. Shaffer, Dale Lee, et al.. (2017). Nutritional Adequacy of the Specific Carbohydrate Diet in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 65(5). 533–538. 29 indexed citations
14.
Suskind, David L., Stanley A. Cohen, M. Brittnacher, et al.. (2017). Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 52(2). 155–163. 98 indexed citations
15.
Lee, Dale, et al.. (2017). Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report. Digestive Diseases and Sciences. 62(8). 2196–2200. 9 indexed citations
16.
Lee, Dale, et al.. (2017). Dietary Therapies in Pediatric Inflammatory Bowel Disease. Gastroenterology Clinics of North America. 46(4). 731–744. 14 indexed citations
17.
Suskind, David L., et al.. (2010). Nutrition in Pediatric Inflammatory Bowel Disease. Nutrition in Clinical Practice. 25(4). 335–339. 10 indexed citations
18.
Muench, Marcus O., et al.. (2006). Maintenance of Proliferative Capacity and Retroviral Transduction Efficiency of Human Fetal CD38 – /CD34 ++ Stem Cells. Stem Cells and Development. 15(1). 97–108. 3 indexed citations
19.
Suskind, David L., et al.. (2004). Maternal microchimerism in the livers of patients with Biliary atresia. BMC Gastroenterology. 4(1). 14–14. 60 indexed citations
20.
Muench, Marcus O., David L. Suskind, & Alicia Bárcena. (2002). Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver. Biological Procedures Online. 4(1). 10–23. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale Lee Breakdown of academic impact, for papers by Raja Affendi Raja Ali Breakdown of academic impact, for papers by Charlotte Hedin Breakdown of academic impact, for papers by Eun Soo Kim Breakdown of academic impact, for papers by Susan J. Connor Breakdown of academic impact, for papers by Jonas Zeitz Breakdown of academic impact, for papers by Masaya Sasaki Breakdown of academic impact, for papers by Joseph H. Sellin Breakdown of academic impact, for papers by Gauree G. Konijeti Breakdown of academic impact, for papers by Anna Pulimood
Rankless by CCL
2026